Biora Therapeutics | DEFA14A: Others
Biora Therapeutics | DEF 14A: Definitive information statements
Biora Therapeutics | PRE 14A: Preliminary proxy statements relating to merger or acquisition
Biora Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Biora Therapeutics | 8-K: Current report
Biora Therapeutics | 8-K: Biora Therapeutics Provides Corporate Update and Reports Fourth Quarter and Full-Year 2023 Financial Results
Biora Therapeutics | 8-K: Current report
Biora Therapeutics | 8-K: Current report
Biora Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Biora Therapeutics | 8-K: Current report
Biora Therapeutics | 8-K: Current report
Biora Therapeutics | 8-K: Current report
Biora Therapeutics | 8-K: Biora Therapeutics Provides Corporate Update and Reports Third Quarter 2023 Financial Results
Biora Therapeutics | 8-K: Current report
Biora Therapeutics | 8-K: Current report
Biora Therapeutics | 8-K: Current report
Biora Therapeutics | 8-K: Current report
Biora Therapeutics | 8-K: Biora Therapeutics Provides Corporate Update and Reports Second Quarter 2023 Financial Results
Biora Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Biora Therapeutics | 8-K: Current report
No Data